BlackRock Health Sciences Term Trust (BMEZ) to Issue Monthly Dividend of $0.11 on January 30th

BlackRock Health Sciences Term Trust (NYSE:BMEZ) announced a monthly dividend on Friday, January 2nd. Stockholders of record on Tuesday, January 20th will be paid a dividend of 0.11 per share on Friday, January 30th. This represents a c) dividend on an annualized basis and a dividend yield of 8.6%. The ex-dividend date of this dividend is Tuesday, January 20th.

BlackRock Health Sciences Term Trust Trading Down 0.1%

Shares of NYSE:BMEZ opened at $15.40 on Friday. The firm’s 50 day simple moving average is $15.17 and its 200 day simple moving average is $14.68. BlackRock Health Sciences Term Trust has a fifty-two week low of $12.58 and a fifty-two week high of $16.75.

Insiders Place Their Bets

In other news, Director Robert W. Fairbairn sold 10,294 shares of BlackRock Health Sciences Term Trust stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $14.98, for a total transaction of $154,204.12. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Institutional Trading of BlackRock Health Sciences Term Trust

Several hedge funds have recently added to or reduced their stakes in BMEZ. TrueMark Investments LLC grew its stake in BlackRock Health Sciences Term Trust by 91.9% in the fourth quarter. TrueMark Investments LLC now owns 48,567 shares of the company’s stock valued at $731,000 after acquiring an additional 23,263 shares during the period. DAVENPORT & Co LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the 4th quarter valued at approximately $207,000. PMG Family Office LLC bought a new stake in BlackRock Health Sciences Term Trust during the 3rd quarter worth approximately $411,000. Allworth Financial LP raised its holdings in BlackRock Health Sciences Term Trust by 24,584.6% during the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock worth $46,000 after buying an additional 3,196 shares during the period. Finally, NewEdge Advisors LLC lifted its stake in BlackRock Health Sciences Term Trust by 17.9% in the third quarter. NewEdge Advisors LLC now owns 56,941 shares of the company’s stock valued at $821,000 after buying an additional 8,641 shares in the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.